Cellectar stock price
Get breaking news and analysis on Cellectar Biosciences, Inc. (CLRB) stock, price quote and chart, trading and investing tools. Cellectar Biosciences Inc. Stock Price (CLRB) | Barron's View today's stock price, news and analysis for Cellectar Biosciences Inc. (CLRB). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation CLRB: Cellectar Biosciences Inc - Stock Price, Quote and ...
CLRBZ | Complete Cellectar Biosciences Inc. Wt Series A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
CLRB - Stock quote for CELLECTAR BIOSCIENCES, INC. - MSN … View the latest CLRB stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of CELLECTAR BIOSCIENCES, INC.. Cellectar BioSciences (CLRB) Stock Price History | wallmine Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micro metastatic disease; CLR 124 which could detects tumors and metastases in a broad range of cancers; and CLR 1502, a cancer Cellectar Biosciences Inc (CLRB) Quote | Morningstar Learn about CLRB with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on CLRB.
View the real-time CLRB price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Cellectar Biosciences against related stocks people have also bought like NIO, GERN, ACB, and OGEN. 869 people own Cellectar Biosciences on Robinhood on April 4, 2020.
19 Feb 2020 Cellectar Biosciences to hold a conference call. Key Opinion Leader Dr. Sikander Ailawadhi provides an update of the CLR 131 Phase 1 and 20 Aug 2019 The purchase prices were between $16.03 and $31.1, with an estimated average price of $21.03. The stock is now traded at around $38.83. The 14 Feb 2020 That led to a 4% rise in the stock price. Read More. What Penny Penny Stocks To Buy [or sell]: Cellectar Biosciences. Cellectar Biosciences 23 May 2019 The shares of common stock and warrants were sold at $2.50 per fixed years after the date of issuance, and have an exercise price of $2.40.
Cellectar Biosciences, Inc. Common Stock (CLRB) Stock ...
The following presents a detailed Cellectar Biosciences stock price history for your review. To help provide a sense of the short to long-term trend, included is an interactive Cellectar Biosciences stock chart which you can easily adjust to the time frame of your choosing (e.g. using the scroll bar or pinch and zoom on a touch screen).
CLRB: Cellectar Biosciences Inc - Stock Price, Quote and ...
CLRB Cellectar Biosciences, Inc. — Stock Price and ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Cellectar Biosciences Stock Forecast: up to 1260.690 USD ... Historical index on US Stock Market : D "Should I invest in Cellectar Biosciences stock?" "Should I trade "CLRB" stock today?" According to our live Forecast System, Cellectar Biosciences, Inc stock is an awesome long-term (1-year) investment*. "CLRB" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. CLRB - Cellectar Biosc Stock Price - Barchart.com 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Cellectar Biosciences Stock Quote. CLRB - Stock Price ...
How has Cellectar Biosciences's share price performed over time and what events CLRB, NasdaqCM (Nasdaq Capital Market), Yes, Common Stock, US, USD Learn about CLRB with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a Stock Style. Large-Cap Cellectar Biosciences (Nasdaq: CLRB) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and Our common stock is listed on the Nasdaq Capital Market under the symbol “ CLRB.” On November 22, 2016, the last reported sale price of our common stock on Cellectar Biosciences, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment Stock splits are used by Cellectar Biosciences, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets